Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report

Table 1 Literature review of duodenal obstruction caused by Strongyloides stercoralis infection (1970-2010).

Author	Year	Age	Gender	Country	Associated disease	WBC/eosinophils	Surgery	Diagnosis	Treatment	Outcome
Cohen & Spry¹³	1979	40	M	England	lymphoma	16.500/4%	SB resection	DA, EGD+bx	thiabendazole *	Dead
Zyngier et al.¹⁴	1983	30	M	Brazil	no	NR/0%	gastrojejunostomy	GA, sputum	thiabendazole †	Alive
Lee & Terry¹⁵	1989	15	M	Jamaica	no	4.400/NR	no	stool analysis	thiabendazole ‡	Alive
	1989	19	F	Jamaica	no	10.000/NR	no	DA	thiabendazole	Alive
Friedenberg et al.¹⁶	1999	40	M	USA	HTLV-1 infection	35.500/1%	no	EGD+bx	thiabendazole	Dead
Harish et al.⁹	2005	45	M	India	no	12.000/14%	no	DA, EGD+bx	ivermectin	Alive
Suvarna et al.¹⁷	2005	70	M	India	no	11.000/(220/μL)	no	EGD+bx	ivermectin #	Alive
Juchems et al.¹⁸	2008	63	M	Germany	no	10.500/NR	partial gastrectomy	surgical specimen	ivermectin	Alive
Current case	2010	42	F	Brazil	no	14.900/0%	duodenal resection	surgical specimen	ivermectin + albendazole	Dead

NR, not reported; WBC, white blood cell count; DA, duodenal aspirate; GA, gastric aspirate; EGD, esophagogastroduodenoscopy; SB small bowel; bx, biopsy; HTLV-1, Human T-lymphotropic virus Type I
* small bowel resection after medical treatment for strongyloidiasis showed poorly differentiate small bowel lymphoma
† patient underwent to a gastrojejunostomy; diagnosis was made after surgery by EGD + gastric aspirate
‡ patient presented new episode of duodenal obstruction 6 years after the initial treatment/recurrent strongyloidiasis
# initially treated with albendazole without success.

ISSN: 1749-7922